You are here

Recovery of reward function in problematic substance users using a combination of robotics, electrophysiology, and TMS

Recovery of reward function in problematic substance users using a combination of robotics, electrophysiology, and TMS

Authors: 
Kathryn Biernacki, Mei-Heng Lin, Travis E.Baker
Year: 
2020
Journal: 
International Journal of Psychophysiology
Abstract: 

Background
Theoretical and empirical work suggest that addictive drugs potentiate dopaminergic reinforcement learning signals and disrupt the reward function of its neural targets, including the anterior midcingulate cortex (aMCC) and the basal ganglia. Here, we aim to use prefrontal 10-Hz TMS to enhance aMCC reward activity and reward learning by the basal ganglia in problematic substance users.

Methods
22 problematic substance users were randomized into an Active and SHAM (coil flipped) TMS group. We recorded the reward positivity—an electrophysiological signal believed to index sensitivity of the aMCC to rewards—while participants engaged in 4 blocks (100 trials per block) of a reward-based choice task. A robotic arm positioned a TMS coil over a prefrontal cortex target, and 50 pulses were delivered at 10-Hz before every 10 trials of blocks 2–4 (1500 pulses, 400 trials). Participants then completed a decision-making task that is diagnostic of striatal dopamine dysfunction.

Results
The present study revealed three main findings. First, both groups failed to elicit a reward positivity during the first two task blocks. Second, applying robot-assisted TMS enhanced the amplitude of the reward positivity in the Active group, but not the SHAM group, across the last two task blocks. Third, the Active group performed relatively better at reward-based learning than the SHAM group.

Conclusion
These results demonstrate that 10-Hz TMS is successful in modulating the reward function of the aMCC and basal ganglia in problematic substance users, which may have utility in the treatment of reward-related neural dysfunction commonly associated with substance use disorders.

Read more >>>

© Copyright 1999 - 2021 ANT Neuro | www.ant-neuro.com | Terms of Use | Privacy Statement | Contact | USA Customers